Skip to content

Accuracy of Dental Implant Placement Using Two Different CBCT-derived Templates

Accuracy of Dental Implant Placement Using Two Different CBCT-derived Templates: a Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02772172
Enrollment
30
Registered
2016-05-13
Start date
2016-08-31
Completion date
2018-02-28
Last updated
2016-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaw, Edentulous, Partially

Brief summary

The main purpose of the present study is to evaluate the dental implant placement using two different CBCT-derived templates and to study the related factors that affect accuracy so as to support the further clinical application of the technique. Thirty patients with partial edentulous denture are recruited. They are randomized to two groups. A radiographic guide is prepared before CT/CBCT scan. The CT/CBCT scan DICOM files are loaded in a planning program and converted into 3D computer images. A surgical template is fabricated through this virtual planning. After 6 weeks, if the implants are judged stable, the patient has the option of replacing the fixed prosthesis. Patients are recalled for oral hygiene maintenance and prosthetic controls every 6 months for the entire duration of the study.

Interventions

DEVICESurgical Template

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Partial edentulism * Missing more than three teeth in succession * Presence of adjacent teeth * Systemically healthy * Good maxillomandibular relation * Maximal mouth opening\>5 mm

Exclusion criteria

* Poor oral hygiene * Severe parafunctional habits, for example, bruxing and clenching * Presence of clinically active periodontal disease as expressed by probing pocket depths≥4 mm in combination with bleeding on probing * Maxillary sinus involvement * Conditions that might lead to a possibly lowered regenerative capacity of the bone, for example, osteoporosis and Paget's disease * Pregnant or expecting to be pregnant * History of drug and alcohol abuse * History of systemic diseases that would contraindicate oral surgical treatment, for example, uncontrolled diabetes (defined as HBA1c level \>7%) * Radiotherapy in the head and neck area * On certain medications like bisphosphonates or steroids currently or within the past three months * Unwillingness to return for the follow-up examination * Smokers (more than20 cigarettes per day). Subjects smoking \<20 cigarettes per day were requested to stop smoking before and after surgery

Design outcomes

Primary

MeasureTime frameDescription
Position changes between the planned and achieved implant positionChange from preoperative to postoperative within 1 weekAccuracy analysis. The linear and angular deviations between the planned and achieved implant position are analyzed.

Secondary

MeasureTime frameDescription
Radiographic bone levelUp to 18 months after baselineRadiographic bone level will be recorded at 6 months,12months and 18 months
The incidence of biological and mechanical complicationsUp to 18 months after baselineThe incidence of biological and mechanical complications will be recorded at baseline, 6 months,12months and 18 months
Probing depthUp to 18 months after baselineProbing depth will be recorded at 6 months,12months and 18 months
Implant and prosthesis survivalUp to 18 months after baselineImplant and prosthesis survival will be determined at 6 months,12months and 18 months
Modified bleeding indexUp to 18 months after baselineModified bleeding index will be recorded at 6 months,12months and 18 months
Gingival indexUp to 18 months after baselineGingival index will be recorded at 6 months,12months and 18 months
Modified plaque indexUp to 18 months after baselineModified plaque index will be recorded at 6 months,12months and 18 months

Countries

China

Contacts

Primary ContactZhuofan Chen, Professor
1330177020@qq.com+86-20-83862537
Backup ContactXin Liu
838667172@163.com+8615902064014

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026